White label ELPA - ClinicalTrials.eu

Study of lidocaine to reduce opioid use in patients with sickle cell disease experiencing severe pain crisis

Not yet recruiting

3 1 1
Investigated diseases:
- Sickle cell disease
Investigated drugs:
- Lidocaine Hydrochloride
- Sodium Chloride
A Study of Mibavademab for Weight Loss in Children, Adolescents and Adults with Obesity Caused by LEP Gene Mutations

Not yet recruiting

3 1 1
Testing Antibiotic Treatment Strategies for Patients with Bladder Bacteria Without Symptoms Receiving Botulinum Toxin A Bladder Injections

Not yet recruiting

3 1 1 1
Investigated drugs:
Study of Autologous Tumor-Infiltrating Lymphocytes with Cyclophosphamide, Fludarabine and Aldesleukin in Patients with Germ Cell Tumors

Not yet recruiting

2 1 1 1
Investigated drugs:
Study of Intradialytic Parenteral Nutrition for Muscle Protein Production in Patients on Long-term Hemodialysis Treatment

Not yet recruiting

3 1 1 1
Investigated diseases:
- Haemodialysis
Investigated drugs:
Comparing ropivacaine and bupivacaine for pain relief after hip replacement surgery in patients with hip osteoarthritis

Not yet recruiting

3 1 1 1
Investigated diseases:
Investigated drugs:
- Bupivacaine Hydrochloride
- Ropivacaine Hydrochloride
A study testing magnesium aspartate to prevent long-term low parathyroid hormone levels in patients after thyroid surgery

Not yet recruiting

3 1 1
Investigated diseases:
- Hypoparathyroidism
Investigated drugs:
- MAGNESIUM L-ASPARTATE HYDROCHLORIDE TRIHYDRATE
A Study of Candesartan to Prevent Chronic Cluster Headache Attacks in Adults with Chronic Cluster Headache

Not yet recruiting

3 1 1
Investigated diseases:
- Cluster headache
Investigated drugs:
- Candesartan
A Study of Doravirine for Early Treatment of West Nile Virus Infection in Patients at Risk of Disease Worsening

Not yet recruiting

2 1 1 1
Investigated drugs:
- Doravirine
Study Using Gallium-68 FAPI PET/MRI Imaging to Measure Disease Activity in Patients with Graves’ Eye Disease

Not yet recruiting

1 1 1
Investigated diseases:
- Endocrine ophthalmopathy
Investigated drugs:
- (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies